Hypogonadism Completed Phase 3 Trials for Testosterone (DB00624)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00702650A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) FormulationsTreatment
NCT00857454A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion FormulationsTreatment